Details of the Drug
General Information of Drug (ID: DMDLK9G)
| Drug Name |
C-(1H-Indol-3-yl)-methylamine
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
(1H-Indol-3-yl)methanamine; 22259-53-6; 1H-Indole-3-methanamine; 3-(aminomethyl)indole; 1H-indol-3-ylmethanamine; Indol-3-ylmethylamine; 1H-Indol-3-ylmethylamine; 3-aminomethylindole; CHEBI:65009; CHEMBL6509; C-(1H-Indol-3-yl)-methylamine; 3-Indolylmethylamine; Indole-3-methanamine; 3-Aminomethyl indole; AC1LAOER; 3-(aminomethyl) indole; 1H-indol-3-ylmethyl amine; Indole, 3-(aminomethyl)-; 1H-indol-3-yl-methyl-amine; SCHEMBL701395; AC1Q548H; C-(1H-indol-3-yl)methylamine; 1-(1H-indol-3-yl)methanamine; JXYGLMATGAAIBU-UHFFFAOYSA-
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 146.19 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 0.8 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


